Clinical Trials
All Clinical Trials - Page 7 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT07338214Phase 1Completed
Investigating the Pharmacokinetics of Petrelintide Using Different Drug Product Concentrations
Petrelintide
- NCT07277439Phase 2Recruiting
Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ Adenocarcinoma
Thymosin-Alpha-1
- NCT07285629EARLY_Phase 1Completed
Safety and Efficacy of Klotho and Follistatin Gene Therapy
Follistatin
- NCT07313761Phase 1Completed
A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous Presentations
Maridebart-Cafraglutide
- NCT07307235Phase 4Recruiting
Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents
Lixisenatide
- NCT07276763N/ANot Yet Recruiting
Impact of Discontinuing GLP-1 Receptor Agonists for Two Weeks Prior to Upper Endoscopy on the Risk of Gastric Retention
Semaglutide
- NCT07326111Phase 4Recruiting
A Clincial Study Testing Tirzepatide on Reproductive Function and Metabolic Health in Women With PCOS Who Are Overweight or Obese
Tirzepatide
- NCT07224438Phase 2Recruiting
Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea
Kisspeptin
- NCT07229170N/ARecruiting
Changes in Taste and Eating Habits Associated With GLP-1 Agonists in Weight Loss Patients
Tirzepatide
- NCT07271251Phase 3Completed
A Research Study to See if Two Different Formulations of Oral Semaglutide Are Equally Safe and Effective in Reducing the Blood Sugar Level in Japanese People With Type 2 Diabetes
Semaglutide
- NCT07302802N/ARecruiting
Efficacy of Semaglutide s.c. Once-weekly on Weight Loss and Management in Adolescents With Monogenic Obesity in Clinical Practice
Semaglutide
- NCT07241390Phase 3Recruiting
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Orforglipron
- NCT06692673Phase 1/Phase 2Recruiting
Linaclotide for Colonoscopy Bowel Prep
Linaclotide
- NCT07254715Phase 4Recruiting
Effect of Itopride on Semaglutide Gastroparesis
Semaglutide
- NCT07189624N/ANot Yet Recruiting
Effect of Acute Endurance Exercise on the Production of FGF21 and Follistatin in Patients With Hepatocellular Carcinoma
Follistatin
- NCT07017270Phase 4Recruiting
Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis
Semaglutide
- NCT07275424Phase 2Recruiting
Study of Healthy Aging and Physical Function With Elamipretide
Elamipretide
- NCT06930625Phase 3Recruiting
A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs
Octreotide
- NCT07226765Phase 3Recruiting
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy
Maridebart-Cafraglutide
- NCT07247084Phase 4Recruiting
A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)
Tirzepatide
- NCT06954090Phase 4Enrolling By Invitation
Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study
Semaglutide
- NCT07087054Phase 3Recruiting
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
Octreotide
- NCT07232719Phase 3Active Not Recruiting
A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight
Retatrutide
- NCT07207148N/ARecruiting
People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists
Semaglutide
- NCT06935838Phase 2Completed
Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV
Tirzepatide
- NCT07262762N/ACompleted
Spartina® (Tirzepatide) Effectiveness and Safety Evaluation
Tirzepatide
- NCT07225816Phase 1Recruiting
Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)
Semaglutide
- NCT05933499Phase 2Recruiting
Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With Obesity
Tirzepatide
- NCT07202247Phase 2Recruiting
Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial
Tirzepatide
- NCT07220642Phase 3Active Not Recruiting
Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide
Cagrilintide
- NCT07220759Phase 3Active Not Recruiting
Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide
Cagrilintide
- NCT07221591Phase 1Completed
A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body
Survodutide
- NCT07245771Phase 1/Phase 2Recruiting
Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination With Tirzepatide in Adults With Overweight and Obesity
Tirzepatide
- NCT07223593Phase 3Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Orforglipron
- NCT07128082Phase 2Active Not Recruiting
The Long COVID Treatment Trial
Tirzepatide
- NCT07229157Phase 1Active Not Recruiting
Effect of Maridebart Cafraglutide on the Heart's Electrical Activity
Maridebart-Cafraglutide
- NCT07165028Phase 3Recruiting
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Retatrutide
- NCT07226778Phase 1Completed
Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous (SC) Presentations
Maridebart-Cafraglutide
- NCT07154719Phase 4Recruiting
GLP-1R Actions on Muscle and the Skeleton
Tirzepatide
- NCT06994338Phase 2Recruiting
Tirzepatide for Alcohol Use Disorder
Tirzepatide
- NCT07159451Phase 2Recruiting
A Short-term Preoperative, Evaluating Activity and Safety of Elacestrant Monotherapy as Compared to Elacestrant + Ovarian Function Suppression (LHRH Agonist) in Premenopausal Patients With Stage I-II ER+/HER2- Breast Cancer
Gonadorelin
- NCT06976619Phase 2Recruiting
The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes
Liraglutide
- NCT07220629Phase 2Active Not Recruiting
Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide in Participants With Obesity (RESOLVE-2)
Semaglutide
- NCT07254429Phase 2Recruiting
COMPASS - COpenhagen MenoPAuSe Study
Gonadorelin
- NCT06801015Phase 4Active Not Recruiting
Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions
Tirzepatide
- NCT07156331N/ANot Yet Recruiting
Research on Effects of Drugs on Body Composition and Function With Imaging in Diabetes
Tirzepatide
- NCT07103408Phase 2Not Yet Recruiting
A Study Evaluating Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade for Limited-stage Small Cell Lung Cancer
Thymosin-Alpha-1
- NCT07242612N/ACompleted
Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis
Teriparatide
- NCT07179991N/ANot Yet Recruiting
DDAVP Effect by TEG6 in Cardiac Surgery
Desmopressin
- NCT07156539Phase 3Not Yet Recruiting
A Phase 3 Study of HS-20094 in Patients With T2DM
Dulaglutide